Morning Overview on MSN
New drugs target senescent "zombie" cells, opening a cancer pathway
Chemotherapy kills cancer cells, but it also leaves behind something troubling: damaged cells that stop dividing yet refuse ...
A new set of drugs exploit a recently revealed weakness in "zombie-like"—or senescent—cells that could lead to new treatments ...
Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune system's first line of defense.
Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...
Morning Overview on MSN
Study links extra chromosome sets to tumor spread and cell mobility
Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...
An MSK research team developed a sophisticated method to highlight and track cells with "high plasticity" before and after different treatments in a mouse model of lung cancer. The green cells in this ...
Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...
Researchers found that pancreatic pre-cancer cells mimic dementia by forming clumps of proteins due to faulty recycling processes. These insights could shed light on why pancreatic cancer develops so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results